Clinical Pharmacokinetics of Labetalol
- 1 January 1984
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 9 (2) , 157-167
- https://doi.org/10.2165/00003088-198409020-00003
Abstract
Labetalol was the first of a new class of antihypertensive drugs with both α- and β-adrenoceptor blocking properties present in the same molecule. Its efficacy has been confirmed by double-blind...Keywords
This publication has 43 references indexed in Scilit:
- Synthesis and comparison of some cardiovascular properties of the stereoisomers of labetalolJournal of Medicinal Chemistry, 1982
- Clinical and Pharmacokinetic Studies on the Alpha- and Beta-Blocking Drug LabetalolTherapeutic Drug Monitoring, 1980
- ForumAnaesthesia, 1979
- Drug Kinetics and Hepatic Blood FlowClinical Pharmacokinetics, 1979
- Labetalol: Bioavailability, Drug Plasma Levels, Plasma Renin and Catecholamines in Acute and Chronic Treatment of Resistant HypertensionAustralian and New Zealand Journal of Medicine, 1978
- Decreased first-pass metabolism of labetalol in chronic liver disease.BMJ, 1978
- LABETALOL IN HYPERTENSIONThe Lancet, 1978
- Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.Circulation, 1977
- INTRAVENOUS LABETALOL IN SEVERE HYPERTENSIONThe Lancet, 1975
- Beta adrenergic blockade in hypertension: Practical and theoretical implications of long-term hemodynamic variationsThe American Journal of Cardiology, 1972